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Expression and Regulation of RANTES/CCL5, MIP-1a/CCL3, and
MIP-1b/CCL4 in Mouse Langerhans Cells
To the Editor:
Chemokines can be divided into two categories in terms of
their physiological features, homeostatic and inflammatory
(Moser and Loetscher, 2001). Among the inflammatory
chemokines, regulated on activation of normal T cell ex-
pressed and secreted (RANTES)/CCL5, macrophage in-
flammatory protein (MIP)-1a/CCL3, and MIP-1b/CCL4
(Moser and Loetscher, 2001) are ligands for CCR5. Recent
reports have shown that inflammatory chemokines, such as
CCL3, CCL4, and CCL5, can be induced during maturation/
activation of human monocyte-derived dendritic cells (DC)
and mouse splenic DC (Sallusto et al, 1999; Re and
Strominger, 2001; Vissers et al, 2001). But it remains unclear
whether Langerhans cells (LC), a special subset of DC
localized in epidermis, are capable of expressing CCL3,
CCL4, and CCL5, except for the reports that LC express
mRNA for CCL3 both in humans and mice (Heufler et al,
1992; Matsue et al, 1992; Parkinson et al, 1993; Vissers
et al, 2001). Recently, using a modified panning method, we
succeeded in isolating highly purified immature LC (495%)
from mouse skin (Salgado et al, 1999; Tada et al, 2000). The
purified LC in our preparation acquire mature phenotypes
during culture even without stimuli (Salgado et al, 1999).
We used these cells as an in vitro system with negligible
interference from keratinocytes (KC) or KC-derived cyto-
kines, and examined the expression of CCL3, CCL4, and
CCL5 both at the mRNA and at the protein level in freshly
isolated (immature) LC and cultured (mature) LC.
First, using specific primer for CCL3, CCL4, and CCL5,
we employed RT-PCR to assess the gene expression of
these three chemokines in fresh LC and LC cultured for
48 h. The results of RT-PCR showed that CCL5 mRNA
expression was not found in fresh LC, but strongly induced
after 48 h culture (data not shown). On the other hand, both
CCL3 and CCL4 mRNA were expressed equally in fresh LC
and cultured LC (data not shown). Our present observation
of the expression of CCL3 mRNA by LC was consistent with
previous reports (Heufler et al, 1992; Matsue et al, 1992;
Parkinson et al, 1993; Vissers et al, 2001).
Next, ELISA was carried out to determine the actual
amount of protein secreted into culture media at different
time points. As shown in Table I, CCL3 and CCL4 were
produced relatively early, increasing in amount within the
first 6 h of culture. In contrast, CCL5 production was
minimal for the first 24 h, but increased remarkably
thereafter. We also tested the ability of KC to produce
these chemokines. KC were cultured in the same way as LC
for 48 h without stimulation. All three chemokines were
almost undetectable in the supernatant of 48 h cultured KC
(data not shown). We further investigated how the produc-
tion of these three chemokines is regulated by various
stimuli. As shown in Table II, when LC were stimulated with
TNF-a, IFN-g, agonistic anti-CD40 Ab, and Staphylococcus
aureus Cowen 1 (SAC), the production level of CCL5 in the
supernatants was increased significantly. On the other
hand, TGF-b, GM-CSF, IL-4, IL-10, and IL-13 had significant
inhibitory effects on CCL5 production. The patterns of
modulation of CCL3 and CCL4 production were almost
identical, except for the cases using anti-CD40 Ab and IL-
12. TNF-a, GM-CSF, M-CSF, IL-1b, IL-4, IL-10, IL-13, and
lipopolysaccharide (LPS), and SAC significantly enhanced
the production of CCL3 and CCL4. Of note, the effect of
SAC was particularly prominent among them. Anti-CD40 Ab
upregulated CCL3 but not CCL4 production, whereas IL-12
had a slight positive effect on the production of CCL4 but
not on that of CCL3.
Finally, we investigated whether the inflammatory che-
mokines produced by LC are actually chemotactic to T
cells. For this purpose, we carried out a chemotaxis assay
using mouseCCR5-transfected 2B4 T cells as previously
described (Gao et al, 2003). Since LC produced much more
CCL5 than CCL3/4, we focused on CCL5 in this assay, and
used the supernatant of LC cultured for 72 h with or without
100 ng per mL of IFN-g. LC cultured for 72 h produced
CCL5 at 4741  303 pg per mL without stimulation and
at 7685  301 pg per mL in the presence of IFN-g as
determined by ELISA (n¼3). As shown in Fig 1, the
supernatants of unstimulated and IFN-g-stimulated LC also
induced cell migration, and this migration was partially
blocked by neutralizing anti-CCL5 mAb. Judging from this
neutralization, the contribution of CCL5 to the migration was
more prominent when the supernatant of IFN-g-stimulated
LC was used rather than that of unstimulated LC. In
addition, factors other than CCL5 were involved in the cell
migration in this experiment.
LC emigrate to the T-cell zone of draining lymph nodes
(LN) following maturation to present antigens to T cells,
although some of them may stay in the skin (Katou et al,
2000, 2003). Therefore, immediate production of CCL3/4
and delayed production of CCL5 should represent distinct
roles. Secretion of CCL3/4 can occur easily when LC are
still in skin. On the other hand, mature LC are likely to
secrete large amounts of CCL5 after their arrival in draining
LN. Curiously, LC secreted extremely large amounts of
Abbreviations: KC, keratinocytes; LC, Langerhans cells; SAC,
Staphylococcus aureus Cowen 1
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CCL3/4 when stimulated with SAC. Stimulation with LPS
also upregulated CCL3/4 production, although to a lesser
extent. In contrast, CCL5 production was enhanced only
slightly by SAC and not at all by LPS. The expression of Toll-
like receptor (TLR)2 (receptor for SAC) and TLR4 (receptor
for LPS) by LC was verified in our previous report (Mitsui
et al, 2004). Considering the different kinetics between
Table I. Time course of chemokine production by Langerhans cells (LC)
Time 0 h 6 h 12 h 24 h 48 h
CCL3 (pg per mL) 5.2  0.5 37.3  3.8 54.4  9.7 65.0  7.7 111.5  11.1
CCL4 (pg per mL) 8.7  0.5 38.3  4.8 40.4  3.7 41.0  3.4 57.6  10.6
CCL5 (pg per mL) 74.0  2.3 93.0  9.2 100.0  14.8 124.0  4.7 1884.0  107.8
Production of inflammatory chemokines during the maturation of LC. Purified LC (1.5  106 per mL) were cultured without stimulation, and the
concentration of CCL3, CCL4, and CCL5 was measured at different time points (0, 6, 12, 24, 48 h) in the supernatants by ELISA kit. Results are
mean  (SD) (n¼3). Representative data of three independent experiments.
Table II. Chemokine production by Langerhans cells (LC) cultured for 48 h
Stimuli None TGF-b TNF-a GM-CSF M-CSF IFN-c IL-1b
CCL3
(pg per mL)
111.7  6.3 83.9  4.3b 183.8  10.9a 334.5  18.8a 185.5  34.3a 99.9  10.2 369.2  38.7a
CCL4
(pg per mL)
67.9  2.7 53.5  1.4b 91.4  1.9a 127.1  4.0a 100.5  19.7a 64.3  4.2 89.1  11.9a
CCL5
(pg per mL)
1183.8  22.7 764.8  75.9b 2133.0  230.2a 828.8  135.3b 1190.0  78.1 3503.5  578.9a 1114.8  54.8
Stimuli IL-4 IL-10 IL-12 IL-13 IL-18 Anti-CD40 Ab LPS SAC
CCL3
(pg per mL)
248.7  23.7a 156.6  7.7a 107.3  8.5 186.0  32.1a 110.3  15.7 156.7  13.0a 183.9  37.7a 1761.4  217.9a
CCL4
(pg per mL)
114.9  2.7a 96.4  4.1a 80.0  5.2a 96.3  3.9a 71.3  3.4 71.0  6.5 95.1  7.5a 232.6  17.0a
CCL5
(pg per mL)
475.5  50.9b 628.3  66.7b 1194.8  115.1 649.3  214.9b 1174.0  222.4 1756.3  338.1a 1247.0  72.5 1436.0  127.0a
ELISA of CCL3, CCL4, and CCL5 in culture supernatants of LC. LC (1.5  106 per mL) were cultured for 48 h with or without various stimuli. Results
are mean  (SD) (n¼4). Concentration of each stimulator was as follows: TGF-b, 1 ng per mL; TNF-a, 10 ng per mL; GM-CSF, 1 ng per mL; M-CSF, 1 ng
per mL; IFN-g, 100 ng per mL; IL-1b, 10 ng per mL; IL-4, 10 ng per mL; IL-10, 10 ng per mL; IL-12, 2 ng per mL; IL-13, 10 ng per mL; IL-18, 100 ng per
mL; anti-CD40 Ab, 20 mg per mL; lipopolysaccharide (LPS), 1 mg per mL; Staphylococcus aureus Cowen 1 (SAC), 1:10,000 dilution.
aSignificant increase (po0.05) compared with the unstimulated group.
bSignificant decrease (po0.05) compared with the unstimulated group. Representative data of three independent experiments.
Figure1
Chemotaxis assay was carried out using mouse CCR5-transfected
2B4 T cells (Gao et al, 2003). Chemotaxis of the transfectant was
assessed in 24-well transwells equipped with 5 mM pore polycarbonate
membranes. Cells (1  106) suspended in 100 mL of medium were
transferred to the upper chamber. Culture supernatants of 72 h cultured
Langerhans cells (LC) with or without IFN-g and medium with or without
10 ng per mL of rCCL5 were preincubated with or without 1 mg per mL
of anti-CCL5 mAb for 30 min at room temperature. They were then
transferred to the lower chamber in 600 mL for each group. After an
incubation period of 3 h at 371C, the upper chambers were removed,
and the cells in the lower chamber of each well were collected and
counted. Medium alone served as a negative control. Medium
containing 10 ng per mL of rCCL5 served as a positive control.
Representative data of three independent experiments. Mean  (SD)
(n¼3).
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CCL3/4 and CCL5 production, these results overall indicate
that CCL3/4 produced by LC play a more important role
than CCL5 in early innate immune responses to bacteria
through the recruitment of effector cells into the skin.
Interestingly, some of the stimulators of CCL3/4 production,
such as GM-CSF, IL-4, IL-10, and IL-13, acted in the
opposite for CCL5 production. Since CCL5 shares the
receptor CCR5 with CCL3/4, the reciprocal regulation of
CCL5 production in response to these stimuli may serve as
a late negative feedback mechanism against early immune
responses elicited by CCL3/4. Although KC are also
capable of producing some chemokines, production is
often regulated differently between KC and LC (Li et al,
1996; Wakugawa et al, 2001; Xiao et al, 2003a, b), indicating
an essential role for LC as the source of chemokines in skin.
Understanding the overall mechanism of chemokine pro-
duction will definitely contribute toward solving the com-
plexity of cutaneous inflammation.
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